Semax
A synthetic ACTH(4-10) derivative studied for neuroprotective and cognitive effects, historically used in stroke research in Russia.
Research status: Approved as a prescription nasal spray in Russia; not approved elsewhere.
This page is a research-orientation summary, not a dosing guide. For anything beyond general background, read the primary literature or talk to a qualified clinician — specifics like amount, frequency, or administration aren't something we publish here.
Selected references
- Brain Research · 2006 Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus
- BMC Genomics · 2014 The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia
- Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova · 2018 The efficacy of semax in the treatment of patients at different stages of ischemic stroke
- Journal of Molecular Neuroscience · 2010 Comparison of the temporary dynamics of NGF and BDNF gene expression in rat hippocampus, frontal cortex, and retina under Semax action
Curated from published literature for research orientation. Not an exhaustive review, and not a substitute for reading primary sources.
Related in Cognitive